Please assess the completion status of the following clinical trial:

Trial Title: Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men who have sex with men or transgender women HIV-infected with prior participation in SABES study in Lima Peru OR Established HIV infection OR HIV uninfected~Exclusion Criteria:~* counter-indication for use of study antiretroviral drugs

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Early ART initiation (Type: OTHER): Immediate ART initiation at the time of HIV diagnosis; daily dose of combination ART (one pill/day)
- Deferred ART initiation (Type: OTHER): ART initiation at 24 weeks after HIV diagnosis; daily dose of combination ART (one pill/day)

Based on this trial design, predict the completion outcome and termination type (if applicable).